🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
100 results for “Sandoz”
MedicineActive substanceLicence holderStatus
Jubbonti 60 mg solution for injection in pre-filled syringe
EU/1/24/1813/001
Denosumab Sandoz GmbH
Mycamine 100 mg powder for solution for infusion
EU/1/08/448/002
Micafungin sodium Sandoz Pharmaceuticals d.d.
Mycamine 50 mg powder for concentrate for solution for infusion
EU/1/08/448/001
Micafungin sodium Sandoz Pharmaceuticals d.d.
Omnitrope 1.3mg/ ml Powder and solvent for solution for injection
EU/1/06/332/001
Somatropin Sandoz GmbH
Omnitrope 10 mg/1.5 ml solution for injection in cartridge
EU/1/06/332/007-009
Somatropin Sandoz GmbH
Omnitrope 15 mg/1.5 ml solution for injection in cartridge
EU/1/06/332/010-012
Somatropin Sandoz GmbH
Omnitrope 5 mg/1.5 ml solution for injection in cartridge
EU/1/06/332/004-006
Somatropin Sandoz GmbH
Omnitrope 5mg/ ml Powder and solvent for solution for injection
EU/1/06/332/002-003
Somatropin Sandoz GmbH
Pregabalin Sandoz 100 mg hard capsules
EU/1/15/1011/034-041
Pregabalin Sandoz GmbH
Pregabalin Sandoz 150 mg hard capsules
EU/1/15/1011/042-056
Pregabalin Sandoz GmbH
Pregabalin Sandoz 200 mg hard capsules
EU/1/15/1011/057-062
Pregabalin Sandoz GmbH
Pregabalin Sandoz 225 mg hard capsules
EU/1/15/1011/063-068
Pregabalin Sandoz GmbH
Pregabalin Sandoz 25 mg hard capsules
EU/1/15/1011/001-010
Pregabalin Sandoz GmbH
Pregabalin Sandoz 300 mg hard capsules
EU/1/15/1011/069-083
Pregabalin Sandoz GmbH
Pregabalin Sandoz 50 mg hard capsules
EU/1/15/1011/011-017
Pregabalin Sandoz GmbH
Pregabalin Sandoz 75 mg hard capsules
EU/1/15/1011/018-033
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 100 mg hard capsules
EU/1/15/1012/034-041
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 150 mg hard capsules
EU/1/15/1012/042-056
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 200 mg hard capsules
EU/1/15/1012/057-062
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 225 mg hard capsules
EU/1/15/1012/063-068
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 25 mg hard capsules
EU/1/15/1012/001-010
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 300 mg hard capsules
EU/1/15/1012/069-083
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 50 mg hard capsules
EU/1/15/1012/011-017
Pregabalin Sandoz GmbH
Pregabalin Sandoz GmbH 75 mg hard capsules
EU/1/15/1012/018-033
Pregabalin Sandoz GmbH
Rivastigmine Sandoz 1.5 mg hard capsules
EU/1/09/599/001-003
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH
Rivastigmine Sandoz 2 mg/ml oral solution
EU/1/09/599/017-018
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH
Rivastigmine Sandoz 3 mg hard capsules
EU/1/09/599/005-007
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH
Rivastigmine Sandoz 4.5 mg hard capsules
EU/1/09/599/009-011
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH
Rivastigmine Sandoz 6 mg hard capsules
EU/1/09/599/013-015
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH
Rixathon 100 mg concentrate for solution for infusion
EU/1/17/1185/001-002
Rituximab Sandoz GmbH
Rixathon 500 mg concentrate for solution for infusion
EU/1/17/1185/003-004
Rituximab Sandoz GmbH
Riximyo 100 mg concentrate for solution for infusion
EU/1/17/1184/001-002
Rituximab Sandoz GmbH
Riximyo 500 mg concentrate for solution for infusion
EU/1/17/1184/003-004
Rituximab Sandoz GmbH
Rolcya 60 mg solution for injection in pre-filled syringe
EU/1/25/1958/001
Denosumab Sandoz GmbH
Transiderm-Nitro 10milligram/24 hours Transdermal Patch
PA23311/005/002
Glyceryl trinitrate Sandoz Pharmaceuticals d.d. Marketed
Transiderm-Nitro 15milligrams/24 hours Transdermal Patch
PA23311/005/003
Glyceryl trinitrate Sandoz Pharmaceuticals d.d. Marketed
Transiderm-Nitro 5milligrams/24 hours Transdermal Patch
PA23311/005/001
Glyceryl trinitrate Sandoz Pharmaceuticals d.d. Marketed
Wyost 120 mg solution for injection
EU/1/24/1812/001
Denosumab Sandoz GmbH
Zarzio 30 MU (60 MU/ml) Solution for injection or
EU/1/08/495/1-4,9-12
Ep2006 (recombinant human granulocyte-colony stimulating factor) Sandoz GmbH
Zarzio 48 MU (96 MU/ml) Solution for injection or
EU/1/08/495/5-8,13-16
Ep2006 (recombinant human granulocyte-colony stimulating factor) Sandoz GmbH
Zessly 100 mg powder for concentrate for solution for infusion
EU/1/18/1280/001-005
Infliximab Sandoz GmbH
Ziextenzo 6 mg solution for injection in pre-filled syringe
EU/1/18/1327/001
Pegfilgrastim Sandoz GmbH
Zinacef 1.5 g powder for solution for injection or infusion
PA23311/002/003
Cefuroxime Sodium Sandoz Pharmaceuticals d.d. Marketed
Zinacef 250 mg powder for solution for injection or infusion
PA23311/002/001
Cefuroxime Sodium Sandoz Pharmaceuticals d.d. Marketed
Zinacef 750 mg powder for solution for injection or infusion
PA23311/002/002
Cefuroxime Sodium Sandoz Pharmaceuticals d.d. Marketed
Zinnat 125 mg film-coated tablets
PA23311/003/002
Cefuroxime Sandoz Pharmaceuticals d.d. Marketed
Zinnat 125 mg/5 ml granules for oral suspension
PA23311/003/005
Cefuroxime axetil Sandoz Pharmaceuticals d.d. Marketed
Zinnat 250 mg film-coated tablets
PA23311/003/003
Cefuroxime Sandoz Pharmaceuticals d.d. Marketed
Zinnat 250mg/5ml granules for oral suspension
PA23311/003/001
Cefuroxime axetil Sandoz Pharmaceuticals d.d. Marketed
Zinnat 500 mg film-coated tablets
PA23311/003/004
Cefuroxime Sandoz Pharmaceuticals d.d. Marketed
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.